ACTG trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ACTG achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Acacia Research Corporation (ACTG) has a Wall Street consensus price target of N/A, based on estimates from 7 covering analysts. The company has a market capitalization of $430M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 2 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ACTG trades at a trailing P/E of 20.2x. Analysts expect EPS to grow -131.5% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
IDCCInterDigital, Inc. | $7.1B | $276.02 | $450.00 | +63.0% | Buy | 38.3x | 16 |
VHCVirnetX Holding Corp | $49M | $11.77 | — | — | — | — | — |
XOMAXOMA Royalty Corp. | $550M | $43.89 | $44.50 | +1.4% | Buy | 55.9x | 10 |
QCOMQUALCOMM Incorporated | $192.9B | $182.97 | $218.50 | +19.4% | Hold | 17.0x | 69 |
FORMFormFactor, Inc. | $8.3B | $106.05 | $134.00 | +26.4% | Buy | 43.2x | 19 |
CEVACEVA, Inc. | $1.2B | $42.76 | $45.40 | +6.2% | Buy | 80.9x | 25 |
SIFYSify Technologies Limited | $1.1B | $14.59 | — | — | Buy | — | 1 |
IBMInternational Business Machines Corporation | $287.2B | $306.13 | $314.83 | +2.8% | Buy | 24.6x | 50 |
INTCIntel Corporation | $554.3B | $110.39 | $98.08 | -11.2% | Hold | 102.7x | 84 |
AAPLApple Inc. | $4.6T | $310.66 | $327.00 | +5.3% | Buy | 35.5x | 111 |
Quick answers to the most common questions about buying ACTG stock.
The consensus price target for ACTG is $N/A, close to the current price of $4.45 (N/A% implied move). Based on 7 analyst estimates, the stock appears fairly valued near current levels.
ACTG has a consensus rating of "Buy" based on 7 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
ACTG's current price is $4.45 with a consensus target of $N/A (N/A% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $N/A for ACTG, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. These targets typically reflect 12-month expectations.
ACTG is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 0 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ACTG stock forecast based on 7 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy".
ACTG appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ACTG analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.